Singapore Paincare Holdings Management

Management Kriterienprüfungen 2/4

Singapore Paincare Holdings CEO ist Bernard Lee , ernannt in Dec 2018, hat eine Amtszeit von 5.92 Jahren. besitzt direkt 28.48% der Aktien des Unternehmens, im Wert von SGD5.94M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5.3 Jahre bzw. 4.5 Jahre.

Wichtige Informationen

Bernard Lee

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	5.9yrs
Eigentum des Geschäftsführers	28.5%
Durchschnittliche Amtszeit des Managements	5.3yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	4.5yrs

Jüngste Management Updates

Recent updates

Geschäftsführer

Bernard Lee (55 yo)

5.9yrs

Amtszeit

Dr. Mun Kam Lee, also known as Bernard, is Executive Director and Chief Executive Officer at Singapore Paincare Holdings Limited together with its subsidiaries since 31 December 2018 & serves as it;s Chair...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Mun Kam Lee	CEO & Executive Chairman	5.9yrs	keine Daten	28.48% SGD 5.9m
Lin Siah Peh	Financial Controller	less than a year	keine Daten	keine Daten
Foo Keong Loh	COO & Executive Director	5.3yrs	keine Daten	16.29% SGD 3.4m
Yoen Har Wong	Company Secretary	no data	keine Daten	keine Daten

5.3yrs

Durchschnittliche Betriebszugehörigkeit

50yo

Durchschnittliches Alter

Erfahrenes Management: FRQDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (5.3 ).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Mun Kam Lee	CEO & Executive Chairman	5.9yrs	keine Daten	28.48% SGD 5.9m
Foo Keong Loh	COO & Executive Director	5.3yrs	keine Daten	16.29% SGD 3.4m
Yee Kong Wong	Independent Non-Executive Director	less than a year	keine Daten	keine Daten
Kah Meng Lim	Independent Non-Executive Director	3.7yrs	keine Daten	keine Daten

4.5yrs

Durchschnittliche Betriebszugehörigkeit

53.5yo

Durchschnittliches Alter

Erfahrener Vorstand: FRQDie Vorstandsmitglieder gelten als erfahren (4.5 Jahre durchschnittliche Amtszeit).

Singapore Paincare Holdings Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Jüngste Management Updates

Singapore Paincare Holdings Limited, Annual General Meeting, Oct 25, 2024

Singapore Paincare Holdings Limited Announces Changes to the Composition of the Board

Singapore Paincare Holdings Limited Appoints Isaac Peh Lin Siah as Financial Controller, Effective August 22, 2024

High number of new directors

Singapore Paincare Holdings Limited Announces the Appointment of Soh Chiong Siong as Financial Controller, Effective April 22, 2024

Insufficient new directors

Recent updates

Full year 2024 earnings released: EPS: S$0.011 (vs S$0.004 loss in FY 2023)

Singapore Paincare Holdings Limited, Annual General Meeting, Oct 25, 2024

Singapore Paincare Holdings Limited Announces Changes to the Composition of the Board

Full year 2024 earnings released: EPS: S$0.012 (vs S$0.003 loss in FY 2023)

Singapore Paincare Holdings Limited Appoints Isaac Peh Lin Siah as Financial Controller, Effective August 22, 2024

New minor risk - Dividend sustainability

Now 23% undervalued

High number of new directors

Singapore Paincare Holdings Limited Announces the Appointment of Soh Chiong Siong as Financial Controller, Effective April 22, 2024

Insufficient new directors

Now 22% undervalued after recent price drop

Singapore Paincare Holdings Limited Announces Yap Beng Tat, Richard Resigns as Independent Non-Executive Director

Singapore Paincare Holdings Limited Announces Resignation of Lim Mong Ai, Karen as Financial Controller

Now 20% undervalued

Singapore Paincare Holdings Limited Proposes Final Dividend (Tax Exempt One-Tier) for the Financial Year Ended 30 June 2023, Payable on November 17, 2023

Full year 2023 earnings released: S$0.003 loss per share (vs S$0.022 profit in FY 2022)

Singapore Paincare Holdings Limited Proposes Final Dividend (Tax Exempt One-Tier) for the Financial Year Ended 30 June 2023

Singapore Paincare Holdings Limited, Annual General Meeting, Oct 27, 2023

Full year 2023 earnings released: S$0.003 loss per share (vs S$0.022 profit in FY 2022)

Singapore Paincare Holdings Limited to Report Fiscal Year 2023 Results on Aug 29, 2023

New minor risk - Financial data availability

Singapore Paincare Holdings Limited Appoints Lim Mong Ai, Karen as Financial Controller, Effective July 1, 2023

First half 2023 earnings released

Singapore Paincare Holdings Limited Appoints Lim Kah Meng as Chairman of the Remuneration Committee and A Member of the Audit Committee and the Nominating Committee

Upcoming dividend of S$0.012 per share

Singapore Paincare Holdings Limited Approves Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 30 June 2022

Full year 2022 earnings released: EPS: S$0.022 (vs S$0.013 in FY 2021)

Singapore Paincare Holdings Limited Announces Cessation of Chong Weng Hoe as Independent Non-Executive Director, Chairman of Remuneration Committee and Member of the Audit Committee and Nominating Committee

Full year 2022 earnings released: EPS: S$0.022 (vs S$0.013 in FY 2021)

Singapore Paincare Holdings Limited Recommends Final Dividend

Singapore Paincare Holdings Limited Announces Promotion of Leow Yong Kin from Financial Controller to Chief Financial Officer

High number of new and inexperienced directors

High number of new and inexperienced directors

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: EPS S$0.013 (vs S$0.031 in FY 2020)

Full year 2021 earnings released: EPS S$0.013 (vs S$0.031 in FY 2020)

Singapore Paincare Holdings Limited Appoints Dr. Lim Kah Meng as Independent Non-Executive Director

First half 2021 earnings released: EPS S$0.004 (vs S$0.01 in 1H 2020)

Singapore Paincare Holdings Limited (Catalist:FRQ) completed the acquisition of 40% stake in KCS Anaesthesia Services Pte. Ltd from Kong Chee Sang.

New 90-day high: S$0.23

Singapore Paincare Holdings Limited (Catalist:FRQ) agreed to acquire 40% stake in Kong Chee Seng fro SGD 2.4 million.

Singapore Paincare Holdings Limited has completed a Follow-on Equity Offering in the amount of SGD 3.96 million.

Full year earnings released - EPS S$0.031

Singapore Paincare Holdings Limited (Catalist:FRQ) entered into agreement to acquire AE Medical Sengkang Private Limited from Wong Shing Yip for SGD 0.17 million.

Singapore Paincare Holdings Limited has completed an IPO in the amount of SGD 5.33412 million.

Geschäftsführer

Amtszeit

Führungsteam

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter